Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Uppsala
Clinical trial register · Sweden

Clinical Trials in Uppsala, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Sweden and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2214 matching records held by the registry are in this view. Synced 12 Nov 2026, 03:17 UTC
2214
Studies in scope
all four open statuses
1237
Recruiting now
open to new participants
362
Lead sponsors
across recruiting studies
Top sites
Stockholm 925 Gothenburg 632 Lund 405 Uppsala 368 Malmö 237
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Uppsala University70 AstraZeneca25 Karolinska Institutet19 Merck Sharp & Dohme LLC18 Uppsala University Hospital17 Janssen Research & Development, LLC15 Boehringer Ingelheim8 GlaxoSmithKline8 Bristol-Myers Squibb7 Vastra Gotaland Region7 Region Örebro County5 AbbVie5 Sanofi5 Region Skane4 Stichting Hemato-Oncologie voor Volwassenen Nederland4 Hoffmann-La Roche3 Uppsala County Council, Sweden3 Pfizer3 AO Innovation Translation Center3 Novo Nordisk A/S3 Umeå University3 Bayer3 Karolinska University Hospital3 Sahlgrenska University Hospital3 Alexander Valdman2 Show all 130
Site location
Stockholm925 Gothenburg632 Lund405 Uppsala368 Malmö237 Linköping230 Umeå194 Örebro189 Solna111 Falun75 Huddinge74 Jönköping70 Helsingborg56 Gävle53 Borås48 Mölndal41 Karlstad41 Kalmar37 Västerås34 Halmstad34 Luleå30 Skövde28 Karlskrona27 Sundsvall25 Eskilstuna25 Show all 143
All 143 locations
Target enrolment
to

Trials with a site in Uppsala

368 of 2214 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Sweden
Start
Recruiting
Tau Pathology in the Brain After Hip or Knee Replacement Surgery
NCT07871487Postoperative Cognitive Dysfunction, Alzheimer Disease, Tauopathies, Neuroinflammation
Uppsala University Hospital
Observational
30
Uppsala
2029-04-01
Not yet open
Boehringer Ingelheim
Phase 3
1,500
Örebro, Stockholm, Uppsala
2027-01-11
Not yet open
Sahlgrenska University Hospital
Phase 4
216
Malmö, Huddinge, Stockholm, Uppsala, Umeå, Sundsvall, Mölndal, Skövde
2027-01-11
Not yet open
NRP + ex Situ HMPO2 vs NRP Alone in DCD Kidney Transplantation
NCT07779187Kidney Transplant, DCD Kidney
Karolinska University Hospital
Not applicable
214
Gothenburg, Malmö, Uppsala
2027-01-01
Not yet open
Prophylactic Treatment of Graves Ophthalmopathy (GO) in Newly Diagnosed Graves' Disease (GD) With Atorvastatin (ATORGO)
NCT07883356Graves Disease, Graves Disease (Basedow's Disease), Graves Orbitopathy, Graves Ophthalmopathy
DrugAtorvastatin
Region Skane
Phase 2
554
Gothenburg, Lund, Malmö, Örebro, Stockholm, Umeå, Uppsala
2026-11-01
Not yet open
Lifestyle Changes, Mushroom Supplementation, and Bupropion to Reduce Adiposity and Cardiometabolic Risk
NCT07806279Cardiometabolic Syndrome, Obesity and Cardiovascular Risk, Overweight , Obesity
DrugBupropion
Uppsala University
Phase 3
250
Uddevalla, Uppsala
2026-10-30
Not yet open
Postoperative Pain in Infants
NCT07856615Postoperative Pain
Uppsala University Hospital
Observational
100
Uppsala
2026-10-30
Recruiting
E-Type - Early Wear of Polyethylene Liners Used in DMC
NCT07863557Osteoarthritis, Osteonecrosis, Dysplasia; Hip
Uppsala University
Phase 4
40
Uppsala
2026-10-08
Recruiting
Fight Osteosarcoma Through European Research Evolving Study Platform From Diagnosis to Relapse
NCT07871864Osteosarcoma, Pediatric Osteosarcoma, Osteosarcoma in Children, Osteosarcoma in Adolescents and Young Adults
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3
530
Gothenburg, Linköping, Lund, Stockholm, Umeå, Uppsala
2026-10-07
Not yet open
Zoll Medical Corporation
Not applicable
800
Uppsala
2026-10-01
Not yet open
Patients With Long-stay at ICU: Factors and Evaluation - Feasibility Study
NCT07851974Frailty, Delirium Confusional State, Persistent Critical Illness, Post-Intensive Care Syndrome
Uppsala University
Observational
300
Falun, Hudiksvall, Mora, Uppsala
2026-10
Not yet open
Radiographic Stability of Hip Prosthesis Prior to Revision Surgery
NCT06924567Loosening, Prosthesis, Hip Arthropathy
Georgios Tsikandylakis, MD PhD
Observational
600
Gothenburg, Hässleholm, Stockholm, Uppsala
2026-09-15
Recruiting
Uppsala University
Not applicable
110
Uppsala
2026-09-15
Not yet open
REcovery After Cancer Application
NCT07642492Oesophageal Cancer, Gastric Cancer (Diagnosis)
Karolinska Institutet
Not applicable
250
Gothenburg, Linköping, Lund, Örebro, Stockholm, Umeå, Uppsala
2026-09-15
Recruiting
Surgery for Thumb Base Osteoarthritis: Joint Replacement vs. Trapeziectomy
NCT07569549Thumb Osteoarthritis, Thumb Carpometacarpal Joint Osteoarthritis, Carpometacarpal (CMC) Joint Arthritis, Basal Thumb Osteoartrithis
Uppsala University
Not applicable
84
Uppsala
2026-09-04
Not yet open
Karolinska Institutet
Not applicable
250
Gothenburg, Malmö, Stockholm, Uppsala
2026-09-01
Recruiting
The HIt HArd and hiT Early in Multiple Sclerosis Trial
NCT07517185Relapsing-remitting Multiple Sclerosis
Uppsala University
Phase 2
60
Falun, Gävle, Karlstad, Uppsala
2026-09-01
Not yet open
Patients´ Experiences of Calorimetry Measurements
NCT07839468Experiences, Burn, Calorimetry, Indirect
Uppsala University Hospital
Observational
20
Uppsala
2026-09
Not yet open
Internet-Based Cognitive Behavioral Therapy and Physical Activity for Insomnia
NCT07794943Insomnia Disorders, Physical Inactivity
Uppsala County Council, Sweden
Not applicable
355
Uppsala
2026-09
Not yet open
MC1R Mutations Associated With Red Hair and Perioperative Anesthesia Complications
NCT07815431Anaesthesia Complication, Perioperative Adverse Events, Red Hair, Melanocortin 1 Receptor
Uppsala University
Observational
100,000
Uppsala
2026-09
Recruiting
Evaluation of a Remote Behavioural Stress Recovery Intervention for Myocardial Infarction Patients Younger Than Fifty-five (BRIM-55): A Feasibility Study
NCT07706816Cardiac Disease, Depression and Quality of Life, Cardiac Distress, Myocardial Infarction
Uppsala University
Not applicable
30
Uppsala
2026-08-28
Recruiting
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
NCT07761117Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)
DrugElecoglipron
AstraZeneca
Phase 3
6,950
Gothenburg, Jönköping, Karlstad, Lund, Mölndal, Örebro, Stockholm, Uppsala
2026-08-24
Recruiting
AstraZeneca
Phase 3
7,000
Falun, Gothenburg, Karlstad, Linköping, Lund, Örebro, Stockholm, Uppsala
2026-08-21
Recruiting
John Neoptolemos
Phase 3
394
Huddinge, Linköping, Malmö, Umeå, Uppsala
2026-08-17
Recruiting
GlaxoSmithKline
Phase 3
800
Uppsala
2026-07-27
Active, closed
UNICANCER
Phase 3
2,450
Gothenburg, Lund, Stockholm, Uppsala
2026-07-20
Recruiting
Boehringer Ingelheim
Phase 3
390
Gothenburg, Lund, Uppsala
2026-07-10
Recruiting
Janssen Research & Development, LLC
Phase 2
230
Falun, Gothenburg, Lund, Stockholm, Uppsala
2026-06-30
Active, closed
AstraZeneca
Phase 2
326
Gothenburg, Lund, Stockholm, Uppsala
2026-06-11
Not yet open
Uppsala University
Not applicable
8
Uppsala
2026-06
Recruiting
Navamedic AB
Phase 4
58
Stockholm, Uppsala, Gothenburg, Lund
2026-05-25
Recruiting
Ipsen
Phase 3
350
Gothenburg, Örebro, Stockholm, Uppsala
2026-05-14
Recruiting
Multicenter Study for External Validation of the TB-NET Score
NCT07903532Tumor Burden, Neuroendocrine (NE) Tumors
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
Observational
400
Uppsala
2026-05-12
Recruiting
Swedish National Parotidectomy Study (SNaPs): Drainless Versus Standard Surgery
NCT07620184Parotid Neoplasms, Post-operative Complications, Seroma as Procedural Complication
Uppsala University Hospital
Not applicable
600
Stockholm, Trollhättan, Uppsala
2026-05-06
Not yet open
Resilience and Recovery After Intimate Partner Violence - Evaluation of the EMBER-IPV Protocol
NCT07606586Intimate Partner Violence, Intimate Partner Violence Against Women, Shame, Domestic Abuse
Uppsala University
Observational
150
Uppsala
2026-05
Recruiting
Janssen Research & Development, LLC
Phase 3
530
Linköping, Mölndal, Stockholm, Uppsala
2026-04-21
Recruiting
How a Resilience-Focused Intervention is Perceived by Women Subjected to Domestic Violence
NCT07235722Shame, Intimate Partner Violence, Domestic Violence Exposure, Resilience, Psychological
Uppsala University
Observational
30
Uppsala
2026-04-07
Recruiting
Boehringer Ingelheim
Phase 2
132
Danderyd, Linköping, Uppsala
2026-03-23
Recruiting
Bristol-Myers Squibb
Phase 3
850
Gävle, Solna, Uppsala
2026-03-16
Recruiting
Sanofi
Phase 2/3
526
Gothenburg, Huddinge, Uppsala
2026-03-13
Active, closed
Gedea Biotech AB
Not applicable
48
Linköping, Solna, Uppsala
2026-03-03
Recruiting
Uppsala University
Observational
2,000
Gothenburg, Lund, Stockholm, Uppsala
2026-03-01
Recruiting
Boehringer Ingelheim
Phase 3
286
Linköping, Lund, Stockholm, Uppsala
2026-02-16
Recruiting
BELUGA: Better to Exchange ETT for LMA Before Extubation in Children Under General Anaesthesia
NCT07204990Endotracheal Extubation, Airway Anesthesia, Paediatric
Telethon Kids Institute
Not applicable
1,400
Uppsala
2026-02-06
Recruiting
Robotic-Assisted Pedicle Screw Placement in Spine Surgery
NCT07461636Pedicle Screw Fixation of Spine
Uppsala University
Observational
7,200
Gothenburg, Jönköping, Kalmar, Linköping, Örebro, Stockholm, Umeå, Uppsala
2026-02-02
Not yet open
Increased Pacemaker Lower Rate in ATTR Cardiac Amyloidosis
NCT07413081Cardiac Amyloidosis, Pacemaker
Region Skane
Not applicable
34
Gothenburg, Linköping, Lund, Skellefteå, Stockholm, Umeå, Uppsala
2026-02-01
Recruiting
A Phase 2 Study of TCP-25 Gel in Patients With Epidermolysis Bullosa, STEP-study
NCT06594393Epidermolysis Bullosa (EB), Dystrophic Epidermolysis Bullosa, Junctional Epidermolysis Bullosa
Xinnate AB
Phase 2
32
Lund, Uppsala
2026-01-30
Recruiting
Uppsala University
Not applicable
200
Gothenburg, Lund, Stockholm, Uppsala
2026-01-09
Recruiting
Novo Nordisk A/S
Phase 3
460
Umeå, Uppsala
2026-01-08
Recruiting
Single-Stapled Technique for Colorectal Anastomosis
NCT07417358Colorectal Cancer, Colorectal Anastomosis, Anastomotic Leakage, Diverticular Disease of Left Side of Colon
Umeå University
Observational
500
Gothenburg, Luleå, Malmö, Umeå, Uppsala
2026-01-07
Recruiting
AstraZeneca
Phase 3
1,100
Linköping, Lund, Solna, Umeå, Uppsala
2025-12-29
Recruiting
Sanofi
Phase 2
144
Örebro, Uppsala
2025-12-29
Recruiting
Treating Emergency Laparotomy Incisions With Negative Pressure Wound Therapy
NCT07003906Surgical Incision, Wound Dehiscence, Surgical Site Infection, Incisional Hernia
Uppsala University
Not applicable
720
Eskilstuna, Linköping, Mora, Norrköping, Uppsala, Västerås
2025-12-16
Recruiting
Region Örebro County
Phase 4
350
Örebro, Uppsala
2025-12-15
Recruiting
Open TAP-block in Pediatric Abdominal Surgery
NCT07352683Pain Management After Surgery
Uppsala University
Not applicable
88
Uppsala
2025-12-01
Recruiting
Comparing ACT, Recuperation, and ACT Plus Vocational Support for Clinical Burnout
NCT07272421Burnout, Clinical Burnout, Exhaustion Disorder
Uppsala University
Not applicable
400
Uppsala
2025-12-01
Recruiting
Debiopharm International SA
Phase 3
119
Stockholm, Uppsala
2025-11-26
By invitation
Optical Coherence Tomography in Acute Vessel Evaluation
NCT07422688Ischemic Heart Disease, Ischemic Coronary Artery Disease, ACS (Acute Coronary Syndrome)
Aarhus University Hospital Skejby
Not applicable
3,000
Danderyd, Gothenburg, Luleå, Stockholm, Uppsala
2025-11-23
Recruiting
Therese Hössjer
Not applicable
200
Uppsala
2025-11-20
Active, closed
Uppsala University
Observational
16,000
Uppsala
2025-11-06
Recruiting
Magnus Nilsson
Phase 3
262
Gothenburg, Lund, Örebro, Stockholm, Uppsala
2025-11-05
Recruiting
Study on Orthosis in Cervical Spine Fracture Treatment
NCT06848660Cervical Spine Fractures, Cervical Spine Injury, Rigid Collar
Uppsala University Hospital
Not applicable
616
Gothenburg, Linköping, Lund, Malmö, Umeå, Uppsala
2025-11-01
Recruiting
Uppsala University
Observational
350
Uppsala
2025-10-23
Active, closed
Bristol-Myers Squibb
Phase 2/3
470
Lund, Stockholm, Uppsala, Gothenburg
2025-10-23
Recruiting
GlaxoSmithKline
Phase 1/2
47
Lund, Stockholm, Uppsala
2025-10-20
Not yet open
Minimal Invasive Scoliosis or Open Surgery
NCT07203586Idiopathic Adolescent Scoliosis, Idiopathic Juvenile Scoliosis
Uppsala University
Not applicable
180
Uppsala
2025-10-15
Recruiting
Karolinska Institutet
Not applicable
350
Stockholm, Gothenburg, Malmö, Uppsala
2025-10-06
Recruiting
Affibody
Phase 1
21
Gothenburg, Stockholm, Uppsala
2025-10-06
Recruiting
Janssen Research & Development, LLC
Phase 2/3
1,092
Allingsas, Gothenburg, Linköping, Örebro, Stockholm, Uppsala
2025-10-03
Active, closed
Janssen Research & Development, LLC
Phase 3
896
Allingsas, Gothenburg, Linköping, Örebro, Stockholm, Uppsala
2025-10-01
Recruiting
Sanofi
Phase 3
124
Huddinge, Uppsala
2025-09-26
Recruiting
Improved Oral Health in Head and Neck Cancer Survivors
NCT07173270Head and Neck Cancer Squamous Cell Carcinoma, Head and Neck Cancer
Uppsala University
Not applicable
300
Uppsala
2025-09-25
Recruiting
Dietary Impact on Sleep, Rhythms and Related Physiology
NCT07138313Sleep, Diet Interventions, Circadian Rhythm
Uppsala University
Not applicable
24
Uppsala
2025-09-22
Recruiting
Bristol-Myers Squibb
Phase 3
3,040
Lund, Borås, Uppsala
2025-09-22
Recruiting
Uppsala University
Not applicable
96
Kalmar, Linköping, Malmö, Örebro, Stockholm, Umeå, Uppsala
2025-09-17
Recruiting
Bristol-Myers Squibb
Phase 2/3
600
Malmö, Stockholm, Uppsala, Örebro, Linköping
2025-09-11
Recruiting
Alnylam Pharmaceuticals
Phase 3
11,000
Gothenburg, Stockholm, Uppsala
2025-09-06
Recruiting
Promoting Sleep to Alleviate Pain - Arthroplasty
NCT06145516Osteoarthritis, Knee, Osteoarthritis, Hip, Insomnia, Surgery
Uppsala University
Not applicable
100
Uppsala
2025-09-01
Recruiting
Skin Conductance in Ventilated Preterms
NCT07568418Mechanical Ventilation, Pain, Skin to Skin Care, Kangaroo Mother Care
Uppsala University Hospital
Not applicable
50
Uppsala
2025-08-08
Recruiting
AstraZeneca
Phase 3
700
Gothenburg, Malmö, Stockholm, Umeå, Uppsala
2025-08-06
Recruiting
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
227
Gothenburg, Lund, Stockholm, Uppsala
2025-08-05
Recruiting
Bristol-Myers Squibb
Phase 3
450
Nacka, Uppsala, Gothenburg
2025-07-18
Recruiting
Uppsala University
Not applicable
164
Uppsala
2025-07-14
Recruiting
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
NCT06966700Breast Neoplasms, Triple Negative Breast Neoplasms, HR Low-Positive/HER2-Negative Breast Neoplasms
DrugsEpirubicin·Adriamycin·Xeloda·Paraplatin
Merck Sharp & Dohme LLC
Phase 3
2,400
Malmö, Stockholm, Uppsala, Borås
2025-06-30
Recruiting
Long-term Characterization of GORE® TAG® Conformable Thoracic Stent Graft With ACTIVE CONTROL System Performance
NCT06658730Vascular Disease, Dissection, Dissection Aortic Aneurysm, Dissection of Aorta
W.L.Gore & Associates
Observational
1,500
Uppsala
2025-06-19
Recruiting
Bristol-Myers Squibb
Phase 3
274
Nacka, Uppsala, Gothenburg
2025-06-13
Recruiting
GlaxoSmithKline
Phase 1/2
346
Gothenburg, Lund, Stockholm, Uppsala
2025-06-11
Recruiting
BeOne Medicines
Phase 3
630
Gothenburg, Lund, Stockholm, Uppsala
2025-06-11
Active, closed
A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With HeFH
NCT07000136Heterozygous Familial Hypercholesterolaemia
DrugAZD0780
AstraZeneca
Phase 3
473
Gothenburg, Linköping, Lund, Stockholm, Uppsala
2025-06-10
Recruiting
BioNTech SE
Phase 3
480
Lund, Stockholm, Uppsala
2025-06-10
Recruiting
Boehringer Ingelheim
Phase 3
1,755
Örebro, Stockholm, Uppsala
2025-06-09
Active, closed
Incyte Corporation
Phase 3
9
Gothenburg, Lund, Stockholm, Uppsala
2025-06-04
Recruiting
Region Stockholm
Phase 3
1,600
Linköping, Örebro, Stockholm, Umeå, Uppsala
2025-06-03
Recruiting
Karolinska Institutet
Not applicable
80
Uppsala, Styrsö, Boxholm
2025-06-01
Recruiting
Platelet Derived Growth Factor Receptor ß (PDGFRß) Imaging in Cardiac Fibrosis
NCT06956560ST-Elevation Myocardial Infarction (STEMI), Heart Failure With Preserved Ejection Fraction (HFpEF)
Uppsala University
Observational
30
Uppsala
2025-06-01
Recruiting
Suicide Preventive Psychosocial Treatment for Youths
NCT06931639Suicide Attempt, Suicidal and Self-injurious Behavior, Suicide Attempted, Suicide, Attempted
Karolinska Institutet
Not applicable
282
Helsingborg, Kungsbacka, Linköping, Stockholm, Uppsala
2025-05-28
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,123
Lund, Uppsala
2025-05-22
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,440
Malmö, Stockholm, Uppsala
2025-05-13
Recruiting
Vaccination Against Human Papillomavirus (HPV) After Allogeneic Stem Cell Transplantation
NCT06793410Recipients of Allogeneic Stem Cell Transplantation, HPV (Human Papillomavirus)-Associated, Acute Myeloid Leukaemia, Myelodysplastic Syndrome
Vastra Gotaland Region
Phase 2
100
Lund, Stockholm, Uppsala, Linköping, Gothenburg
2025-05-12
Recruiting
Sophiahemmet University
Not applicable
252
Stockholm, Uppsala, Västra Frölunda
2025-05-12
Recruiting
Oxygen Consumption, Hypoperfusion and Organ Injury After Cardio-pulmonary Bypass
NCT06930443Cardiac Surgery Requiring Cardiopulmonary Bypass
Uppsala University Hospital
Observational
65
Uppsala
2025-05-05
Recruiting
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
448
Gothenburg, Lund, Stockholm, Uppsala
2025-05-05
Recruiting
Registry-randomized Comparison of Rehabilitation Regimens After Flexor Tendon Injury in the Thumb
NCT06836349Flexor Tendon Injury, Rehabilitation Program, Flexor Tendon Rupture, Thumb Injury
Karolinska Institutet
Not applicable
380
Linköping, Örebro, Stockholm, Umeå, Uppsala
2025-05-01
Not yet open
Short- and Long-term Effects of Robot-assisted Plication in Diaphragmatic Paralysis
NCT06919185Diaphragmatic Plication, Diaphragmatic Paralysis, Diaphragmatic Eventration
Uppsala County Council, Sweden
Observational
50
Uppsala
2025-05
Recruiting
Uppsala University
Not applicable
270
Uppsala
2025-04-23
Recruiting
Oxion Biologics AB
Phase 1
32
Uppsala
2025-04-03
Recruiting
Sahlgrenska University Hospital
Observational
220
Gothenburg, Linköping, Luleå, Lund, Örebro, Stockholm, Uppsala
2025-04-01
Not yet open
Predicting Outcomes Using Infra-red SEnsors, a Feasibility Study.
NCT06515080General Anesthetic Drug Adverse Reaction
Uppsala University
Observational
500
Uppsala
2025-03-31
Recruiting
AstraZeneca
Phase 3
600
Linköping, Lund, Stockholm, Uppsala
2025-03-27
Recruiting
Effects of a Healthy Nordic Diet on Atherosclerosis in Patients with Coronary Heart Disease
NCT06701968Coronary Disease, Coronary Arteriosclerosis, Myocardial Infarction, Chronic Coronary Syndrome
Uppsala University
Not applicable
150
Uppsala
2025-03-20
Recruiting
Daiichi Sankyo
Phase 3
582
Lund, Solna, Uppsala
2025-03-19
Recruiting
Thrombolysis in Factor Xa-inhibitors Trial
NCT06878066Stroke, Stroke (in Patients With Atrial Fibrillation), Ischemic Stroke, Acute Ischemic Stroke
DrugsAlteplase·Tenecteplase
Guri Hagberg
Phase 3
300
Stockholm, Lund, Malmö, Umeå, Uppsala
2025-03-14
Recruiting
AstraZeneca
Phase 3
11,300
Gothenburg, Helsingborg, Huddinge, Lund, Mölndal, Norrköping, Stockholm, Uppsala
2025-03-14
Active, closed
Celgene
Phase 3
960
Lund, Solna, Uppsala, Gothenburg
2025-03-13
Recruiting
Improved Treatment for Patients With Long-term Opioid Therapy for Non-cancer Pain in Primary Care
NCT06856733Chronic Pain, Chronic Pain Management, Primary Care
Uppsala County Council, Sweden
Not applicable
110
Gävle, Strängnäs, Uppsala, Örebro
2025-03-10
Recruiting
Contact Radiotherapy for Rectal Cancer
NCT06501053Rectal Cancer
Alexander Valdman
Not applicable
110
Stockholm, Uppsala
2025-03-03
Recruiting
AstraZeneca
Phase 3
5,000
Huddinge, Karlstad, Linköping, Stockholm, Uppsala, Vaxjo
2025-03-03
Recruiting
Question Prompt List in Breast Cancer Patients Planned for Neoadjuvant Chemotherapy
NCT06777420Breast Cancer Early Stage Breast Cancer (Stage 1-3), Neoadjuvant Therapy, Shared Decision Making
Region Örebro County
Not applicable
218
Uppsala, Västerås, Örebro
2025-03-01
Recruiting
Uppsala University
Observational
20
Uppsala
2025-03-01
Recruiting
Study of Acquired Resistance to Alkylator Chemotherapy in Endocrine Neoplasms
NCT07121998Neuroendocrine (NE) Tumors, Endocrine Cancer
Uppsala University
Observational
94
Uppsala
2025-03-01
Recruiting
Reduce Sedentary Behavior During Cancer Treatment - the RedSedCan Study
NCT06719206Breast Cancer, Colorectal Cancer (CRC), Prostate Cancer, Neoadjuvant Therapy
Mälardalen University
Not applicable
210
Uppsala, Västerås
2025-03-01
Active, closed
The Leeds Teaching Hospitals NHS Trust
Observational
550
Gothenburg, Lund, Uppsala
2025-02-04
Recruiting
Aileen Bergström
Not applicable
100
Huddinge, Uppsala
2025-02-03
Recruiting
Fusion or Not - a Study on Low Back Pain
NCT06709391Low Back Pain, Mechanical, Degenerative Disc Disease Lumbar
Uppsala University
Not applicable
90
Gothenburg, Stockholm, Uppsala
2025-02-01
Recruiting
Uppsala Self-Screening of Cardiovascular Health
NCT07614659Cardiovascular Diseases, Hypertension, Dyslipidemias, Diabetes Mellitus
Johan Sundström
Not applicable
45,000
Uppsala
2025-02-01
Recruiting
Evaluation of Radically Open Dialectical Behavior Therapy for Youth At Risk for Developing Severe and Enduring Eating Disorders
NCT06792071Eating Disorders, Anorexia Nervosa, Anorexia Nervosa, Atypical, Feeding and Eating Disorders
Uppsala University Hospital
Not applicable
18
Uppsala
2025-02
Recruiting
Ribocure Pharmaceuticals AB
Phase 2
120
Lund, Mölndal, Stockholm, Uppsala
2025-01-28
Active, closed
Pfizer
Phase 3
1,035
Gävle, Stockholm, Uppsala, Västerås, Jönköping
2025-01-06
Not yet open
International Research Training Group 2804
Observational
100
Uppsala
2025-01-01
Active, closed
Comparison of Efficacy and Safety in Patients Switching From MabThera® to Rixathon® in Relapsing-Remitting Multiple Sclerosis
NCT07235644MS (Multiple Sclerosis), Multiple Sclerosis (MS) - Relapsing-remitting, Multiple Sclerosis (Relapsing Remitting)
Uppsala University
Observational
184
Uppsala
2025-01-01
Recruiting
Janssen Research & Development, LLC
Phase 3
700
Gothenburg, Lund, Stockholm, Uppsala
2024-12-12
Recruiting
SEALion: Study on Supplemental Oxygenation Via Nasal Cannula for Young Children During Intubation
NCT06683599Difficult Airway, Difficult Airway Intubation, Neonate
Vinícius C Quintão, MD, MSc, PhD
Not applicable
240
Uppsala
2024-12-10
Recruiting
Uppsala University
Observational
100
Uppsala
2024-11-24
Active, closed
Daiichi Sankyo
Phase 3
700
Gasteborg, Lund, Uppsala
2024-11-19
Recruiting
NanoEcho AB
Phase 2
12
Uppsala
2024-10-29
Recruiting
Uppsala University
Observational
1,400
Uppsala
2024-10-20
Recruiting
Janssen Research & Development, LLC
Phase 3
1,000
Gothenburg, Lund, Stockholm, Uppsala
2024-10-18
Recruiting
GlaxoSmithKline
Phase 2
393
Stockholm, Uppsala
2024-09-27
Active, closed
Boehringer Ingelheim
Phase 3
1,666
Linköping, Uppsala
2024-09-26
Active, closed
Novo Nordisk A/S
Phase 4
500
Falun, Halmstad, Malmö, Sundsvall, Uppsala
2024-09-17
Recruiting
Uppsala University Hospital
Not applicable
20
Uppsala
2024-09-11
Recruiting
Improved Recovery by Iron Following Surgery With Blood Loss, the IRIS-trial
NCT05744219Surgery, Liver Metastases, Liver Cancer, Pancreas Cancer
DrugFerric Carboxymaltose
Jon Unosson
Phase 3
338
Uppsala
2024-09-04
By invitation
Fibromyalgia and Sleep Disorder Treatment
NCT06786845Fibromyalgia, Sleep Disorder
Uppsala University
Not applicable
60
Uppsala
2024-09-04
Recruiting
A Longitudinal Study of Severe and Enduring Eating Disorders
NCT06752304Eating Disorders, Anorexia Nervosa, Bulimia Nervosa, Binge Eating Disorder
Uppsala University Hospital
Observational
800
Uppsala
2024-09-01
Active, closed
Boehringer Ingelheim
Phase 3
8,371
Danderyd, Gothenburg, Linköping, Lund, Stockholm, Sundsvall, Uppsala
2024-08-30
Active, closed
Alpine Immune Sciences Inc, A Subsidiary of Vertex
Phase 3
605
Danderyd, Gothenburg, Huddinge, Linköping, Uppsala
2024-08-30
Active, closed
Sanofi
Phase 2
229
Linköping, Mölndal, Stockholm, Uppsala
2024-08-29
Active, closed
Umeå University
Observational
69
Uppsala
2024-08-21
Active, closed
Uppsala University
Not applicable
110
Örebro, Uppsala, Umeå, Gothenburg
2024-08-12
Not yet open
A Study on Young Individuals' Mental Health in Sweden
NCT06490120Mental Health Issue, Depression, Anxiety, Well-Being, Psychological
Uppsala University
Observational
3,000
Uppsala
2024-08-12
Recruiting
AstraZeneca
Phase 3
1,018
Falun, Uppsala
2024-08-07
Recruiting
Region Skane
Phase 4
130
Hässleholm, Malmö, Gothenburg, Eksjö, Falun, Mölndal, Östersund, Uppsala
2024-07-31
Recruiting
Janssen Research & Development, LLC
Phase 3
752
Lund, Mölndal, Stockholm, Uppsala
2024-07-25
Active, closed
Merck Sharp & Dohme LLC
Phase 3
686
Lund, Stockholm, Uppsala, Linköping
2024-07-24
Active, closed
Merck Sharp & Dohme LLC
Phase 3
300
Lund, Huddinge, Uppsala, Gothenburg, Örebro
2024-07-16
Recruiting
GlaxoSmithKline
Phase 1
675
Stockholm, Uppsala
2024-07-02
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,530
Gävle, Stockholm, Uppsala, Borås, Gothenburg
2024-06-24
Recruiting
Uppsala University
Observational
150
Uppsala
2024-06-20
Recruiting
AstraZeneca
Phase 3
240
Stockholm, Uppsala
2024-06-20
Active, closed
Celgene
Phase 3
850
Lund, Solna, Uppsala, Linköping
2024-06-19
Recruiting
Vastra Gotaland Region
Phase 3
40
Gothenburg, Linköping, Lund, Stockholm, Umeå, Uppsala
2024-06-10
Recruiting
Immunocore Ltd
Phase 3
680
Gothenburg, Jönköping, Lund, Stockholm, Uppsala
2024-06-05
Recruiting
Treatment of Sleep Apnea to Improve Metabolic Health
NCT06848647Sleep Apnea, Obstructive, Metabolism, CPAP, Patients Above 18 Years
Uppsala University
Observational
600
Uppsala
2024-05-13
Recruiting
Uppsala University
Phase 1/2
18
Stockholm, Uppsala
2024-05-01
Recruiting
Mechanisms of Acute Kidney Injury in Severe Infections
NCT06372444Sepsis, AKI - Acute Kidney Injury, Positron Emission Tomography (PET)
Uppsala University Hospital
Observational
15
Uppsala
2024-05-01
Recruiting
CSL Behring
Phase 2/3
3,110
Huddinge, Stockholm, Uppsala
2024-04-27
Recruiting
Section for Affective Disorders; Northern Stockholm Psychiatry
Phase 2
100
Gothenburg, Stockholm, Uppsala, Örebro
2024-04-19
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,200
Stockholm, Uppsala, Borås
2024-04-14
Recruiting
AstraZeneca
Phase 3
3,850
Alingsås, Gothenburg, Jönköping, Karlstad, Mölndal, Stockholm, Uppsala, Västerås
2024-04-12
Recruiting
Region Örebro County
Phase 3
495
Örebro, Uppsala
2024-04-01
Active, closed
AstraZeneca
Phase 3
2,554
Gävle, Gothenburg, Linköping, Rättvik, Stockholm, Uppsala
2024-03-29
Recruiting
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
NCT06308978Antineutrophilic Cytoplasmic Antibody (ANCA)- Associated Vasculitis (AAV), Idiopathic Inflammatory Myositis (IIM), Systemic Sclerosis (SSc), Systemic Lupus Erythematosus (SLE)
DrugsFT819·Fludara·Bendamustine·Cytoxan
Fate Therapeutics
Phase 1
244
Uppsala
2024-03-28
Active, closed
Merck Sharp & Dohme LLC
Phase 1/2
230
Stockholm, Uppsala
2024-03-28
Active, closed
Uppsala University
Observational
400
Stockholm, Uppsala
2024-03-25
Recruiting
GlaxoSmithKline
Phase 3
864
Gothenburg, Stockholm, Uppsala
2024-03-21
Recruiting
Effects of Exercise Training in Survivors of Lymphoma
NCT06270667Lymphoma, Physical Exercise, Cardiotoxicity, Cardiovascular Diseases
Norwegian School of Sport Sciences
Not applicable
280
Uppsala
2024-03-20
Recruiting
Per-Ola Carlsson
Early Phase 1
2
Uppsala
2024-03-08
Recruiting
First-in-human Study of 225Ac-PSMA-Trillium (BAY 3563254) in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC)
NCT06217822Advanced Metastatic Castration-resistant Prostate Cancer, Prostate Specific Membrane Antigen (PSMA) Expression
Bayer
Phase 1
198
Lund, Stockholm, Uppsala, Gothenburg
2024-03-07
Recruiting
Uppsala University
Not applicable
81
Uppsala
2024-03-04
Recruiting
Validation of Pediatric Sleep Questionnaire on a Swedish Cohort
NCT06367400Obstructive Sleep Apnea, Sleep Disorder, Sleep Disorders in Children, Obstructive Sleep Apnea of Child
Uppsala University
Observational
520
Uppsala
2024-03-01
Recruiting
EPIGUT: EPILEPSY AND GASTROINTESTINAL MICROBIOTA: UNDERSTANDING THERAPY RESPONSE
NCT07253701Epilepsy, Microbiota, Proteomics, Metabolomics
Karolinska Institutet
Observational
1,500
Gothenburg, Linköping, Lund, Stockholm, Umeå, Uppsala
2024-02-27
Active, closed
AstraZeneca
Phase 2
142
Solna, Uppsala
2024-02-22
Recruiting
AstraZeneca
Phase 3
5,250
Gothenburg, Höllviken, Kungsbacka, Lund, Örebro, Stockholm, Umeå, Uppsala
2024-02-21
Active, closed
argenx
Phase 2
103
Gothenburg, Uppsala
2024-02-17
Active, closed
Lung Ultrasound as Alternative to Radiography in Thoracic Surgery
NCT06261411Thoracic Surgery, Ultrasonography
Uppsala University Hospital
Not applicable
140
Uppsala
2024-02-12
Recruiting
TeamBirth-SWE - a Care Process to Improve Safe and Person-centered Intrapartum Care
NCT06926504Person Centered Care, Patient Safety, Patient Satisfaction
Karolinska Institutet
Observational
800,000
Halmstad, Varberg, Östersund, Lund, Uppsala, Karlstad, Stockholm
2024-02-05
Recruiting
Baby Swim As an Intervention for Depressive Symptoms and Lacking Attachment During the Postpartum Period
NCT06807801Depression - Major Depressive Disorder, Attachment, Postpartum
Uppsala University
Not applicable
100
Uppsala
2024-02-01
Active, closed
CarThera
Phase 3
560
Gothenburg, Uppsala
2024-01-29
Active, closed
AbbVie
Observational
427
Stockholm, Uppsala, Gothenburg
2024-01-24
Active, closed
Janssen Research & Development, LLC
Phase 3
838
Lund, Umeå, Uppsala, Varberg
2024-01-22
Active, closed
Boehringer Ingelheim
Phase 1
65
Gothenburg, Uppsala
2024-01-22
Recruiting
Swedish CArdioPulmonary bioImage Study 2
NCT06679777Cardiovascular Diseases, Lung Diseases
Karolinska Institutet
Observational
30,154
Gothenburg, Linköping, Lund, Stockholm, Umeå, Uppsala
2024-01-15
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,310
Stockholm, Uppsala, Gothenburg
2023-12-31
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,314
Stockholm, Uppsala
2023-12-18
Recruiting
Translation and Validation of the COMM and ASI-SR
NCT06084520Opioid Use, Opioid Use Disorder, Alcohol Use Disorder, Pain, Chronic
Uppsala University
Observational
400
Uppsala
2023-12-01
Recruiting
Vastra Gotaland Region
Phase 3
240
Gothenburg, Linköping, Lund, Stockholm, Umeå, Uppsala
2023-12-01
Active, closed
AstraZeneca
Phase 3
1,835
Gothenburg, Linköping, Rättvik, Stockholm, Uppsala
2023-11-07
Recruiting
European Study of Prodromal iNPH
NCT05910944Normal Pressure Hydrocephalus, Hydrocephalus
Johan Virhammar
Observational
140
Gothenburg, Linköping, Stockholm, Umeå, Uppsala
2023-11-01
Not yet open
University of Dublin, Trinity College
Phase 3
952
Linköping, Lund, Örebro, Stockholm, Uppsala
2023-11
Recruiting
Karolinska University Hospital
Phase 2
370
Malmö, Örebro, Stockholm, Umeå, Uppsala
2023-10-26
Active, closed
Summit Therapeutics
Phase 3
1,600
Stockholm, Uppsala
2023-10-26
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,109
Danderyd, Stockholm, Uppsala, Linköping
2023-10-25
Recruiting
Hoffmann-La Roche
Phase 3
182
Lund, Uppsala
2023-10-22
Active, closed
Stichting European Myeloma Network
Phase 3
759
Gothenburg, Linköping, Lund, Uppsala
2023-10-10
Active, closed
AstraZeneca
Phase 1/2
166
Uppsala
2023-09-29
Recruiting
Para-aortic Lymph Node Metastasis in Resectable Pancreatic Cancer
NCT06065891Pancreas Cancer, Pancreas Adenocarcinoma, Lymph Node Metastasis
Jon Unosson
Not applicable
300
Gothenburg, Linköping, Lund, Umeå, Uppsala
2023-09-05
Recruiting
Region Jönköping County
Observational
600
Falun, Eksjö, Jönköping, Kalmar, Uppsala, Örebro, Linköping, Norrköping
2023-09-01
Not yet open
Region Örebro County
Phase 3
220
Gothenburg, Örebro, Uppsala
2023-08-21
Recruiting
GlaxoSmithKline
Phase 3
892
Eskilstuna, Gothenburg, Linköping, Malmö, Stockholm, Uppsala
2023-08-01
Recruiting
University Hospital, Basel, Switzerland
Not applicable
280
Stockholm, Uppsala
2023-07-14
Active, closed
Novo Nordisk A/S
Phase 3
212
Gothenburg, Halmstad, Uppsala
2023-07-07
Active, closed
Hansa Biopharma AB
Phase 3
150
Huddinge, Uppsala
2023-07-03
Active, closed
Population Health Research Institute
Not applicable
5,100
Gothenburg, Huddinge, Jönköping, Karlstad, Lund, Stockholm, Umeå, Uppsala
2023-06-22
Active, closed
Ersta Diakoni
Not applicable
150
Gothenburg, Lund, Nyköping, Stockholm, Sundsvall, Uppsala
2023-06-01
Recruiting
European Aortic Data Collection Project
NCT05896397Complex Abdominal Aortic Aneurysm, Thoracoabdominal Aortic Aneurysm, Aortic Arch Aneurysm, Chronic Aortic Dissection
Cook Research Incorporated
Observational
600
Malmö, Uppsala
2023-05-31
Recruiting
University of Aarhus
Not applicable
554
Gothenburg, Linköping, Malmö, Örebro, Stockholm, Uppsala
2023-05-24
Recruiting
Region Stockholm
Observational
345
Stockholm, Uppsala
2023-05-04
Recruiting
Impact of the Microbiome on Time to Pregnancy and Pregnancy Outcomes in Fertile Women Attempting to Conceive
NCT05127252Pregnancy Complications, Contraception, Pregnancy Loss, Fertility
Karolinska Institutet
Observational
500
Stockholm, Uppsala
2023-04-10
Recruiting
Uppsala Psychosis Cohort
NCT05763966Schizophrenia; Psychosis
Uppsala University
Observational
120
Uppsala
2023-04-01
Active, closed
Janssen Research & Development, LLC
Phase 3
614
Falun, Helsingborg, Uppsala
2023-03-29
Active, closed
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
NCT05739383Primary Prevention of Atherosclerotic Cardiovascular Disease
DrugInclisiran
Novartis Pharmaceuticals
Phase 3
14,012
Gothenburg, Linköping, Lund, Solna, Stockholm, Uppsala, Västerås
2023-03-09
Recruiting
Uppsala University
Not applicable
500
Uppsala
2023-02-01
Active, closed
Karolinska Institutet
Not applicable
200
Uppsala
2023-01-25
Active, closed
AstraZeneca
Phase 3
1,350
Gävle, Linköping, Lund, Stockholm, Uppsala
2022-12-29
Recruiting
NHS Greater Glasgow and Clyde
Not applicable
3,904
Stockholm, Uppsala
2022-12-22
Recruiting
Princess Maxima Center for Pediatric Oncology
Phase 3
160
Gothenburg, Linköping, Lund, Stockholm, Umeå, Uppsala
2022-12-15
Active, closed
AstraZeneca
Phase 3
1,174
Stockholm, Sundsvall, Uppsala
2022-11-28
Recruiting
Structured Contraceptive Counseling During Pregnancy
NCT05550064Contraception, Intrauterine Device, Contraceptive Implant, Long-acting Reversible Contraception
Dalarna University
Not applicable
160
Falun, Karlstad, Örebro, Uppsala
2022-11-19
Active, closed
AstraZeneca
Phase 3
368
Stockholm, Trollhättan, Uppsala
2022-11-10
Recruiting
Bayer
Phase 3
100
Lund, Uppsala, Stockholm - Huddinge
2022-11-08
Recruiting
Sven Löffeler
Phase 3
980
Falun, Gothenburg, Helsingborg, Örebro, Östersund, Stockholm, Umeå, Uppsala
2022-11-04
Recruiting
Lund University Hospital
Phase 3
300
Gothenburg, Lund, Stockholm, Uppsala
2022-11-01
Recruiting
Uppsala University
Not applicable
154
Falun, Uppsala, Örebro
2022-09-14
Recruiting
AO Innovation Translation Center
Observational
300
Uppsala
2022-09-12
Recruiting
Evaluation of a Home-based Parenting Support Program: Parenting Young Children
NCT05935722Intellectual Disability, Attention Deficit Hyperactivity Disorder, Autism Spectrum Disorder
Örebro University, Sweden
Not applicable
60
Enköping, Jönköping, Motala, Tierp, Uppsala
2022-09-08
Recruiting
Uppsala University
Not applicable
80
Lund, Uppsala
2022-09-01
Active, closed
A Study of Zilovertamab Vedotin (MK-2140) as Monotherapy and in Combination in Participants With Aggressive and Indolent B-cell Malignancies (MK-2140-006)
NCT05458297Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Follicular Lymphoma, Richter Transformation Lymphoma
DrugsNemtabrutinib·Zilovertamab vedotin
Merck Sharp & Dohme LLC
Phase 2
189
Lund, Uppsala, Gothenburg
2022-07-21
Recruiting
A Study to Investigate the Pharmacokinetics and ECG Effects of Linaprazan Glurate
NCT05469854Pharmacokinetics, Cardiodynamic ECG, Safety, and Tolerability, GERD
Cinclus Pharma Holding AB
Phase 1
121
Uppsala
2022-07-13
Recruiting
Microbiome and Metabolome Profiles in Couples Undergoing IVF and Reproductive Outcomes
NCT07532629Infertility, Assisted Reproductive Technology, Pregnancy Complications, Pregnancy Loss, Early
Karolinska Institutet
Observational
1,000
Malmö, Stockholm, Uppsala
2022-06-10
Active, closed
Sanofi
Phase 2
48
Huddinge, Uppsala
2022-06-09
Recruiting
Studying Conditioning Regimen In Pediatric Transplantation - AML , SCRIPT-AML
NCT05477589Acute Myeloid Leukemia (AML) in Remission, Stem Cell Transplantation
Vastra Gotaland Region
Phase 3
170
Gothenburg, Lund, Stockholm, Uppsala
2022-06-07
By invitation
Rituximab Treatment for Psychosis And/or Obsessive Compulsive Disorder with Probable Immune System Involvement
NCT04323566Obsessive-Compulsive Disorder, Obsessive-Compulsive Behavior, Schizophrenia, Delusional Disorder
DrugRituximab
Uppsala University Hospital
Phase 2
40
Uppsala
2022-05-01
Recruiting
The Effects of Night Shift Work on Health Across the Menstrual Cycle
NCT06683248Sleep Deprivation, Menstrual Cycle, Brain Health, Metabolism
Uppsala University
Not applicable
60
Uppsala
2022-04-25
Recruiting
OSU6162 as add-on in SSRI/SNRI-resistant Depression
NCT05641623Depression, Depressive Disorder, Treatment-Resistant, Depressive Disorder, Depressive Episode
DrugOSU6162
Göteborg University
Phase 2
180
Lund, Stockholm, Uppsala, Gothenburg
2022-04-21
Recruiting
Scandinavian Humeral Diaphyseal Fracture Trial
NCT04574336Fracture Humerus of Shaft
Kolding Sygehus
Not applicable
287
Stockholm, Umeå, Uppsala
2022-04-04
Active, closed
W.L.Gore & Associates
Observational
259
Malmö, Uppsala
2022-03-23
Recruiting
Mesalamine for Colorectal Cancer Prevention Program in Lynch Syndrome
NCT04920149Lynch Syndrome, Colon Cancer, Colon Neoplasm
Drugs5-ASA·Mesalazine·Mesalamine
Ann-Sofie Backman
Phase 2
150
Gothenburg, Malmö, Stockholm, Umeå, Uppsala
2022-03-21
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,800
Stockholm, Uppsala, Gothenburg
2022-03-15
Active, closed
Uppsala University
Not applicable
200
Uppsala
2022-03-14
Recruiting
Strategic Use of Big Data in Spine Surgery - Testing Digital Prediction of Outcome in Clinical Praxis
NCT05817747Constriction, Pathologic, Spine Degeneration, Surgery, Radiculopathy
Sahlgrenska University Hospital
Not applicable
900
Ängelholm, Malmö, Gothenburg, Stockholm, Sundsvall, Umeå, Uppsala
2022-03-01
Recruiting
Uppsala University Hospital
Not applicable
300
Uppsala
2022-02-21
Active, closed
Vastra Gotaland Region
Phase 3
50
Stockholm, Uppsala, Gothenburg
2022-02-01
Active, closed
Uppsala University Hospital
Phase 1/2
66
Uppsala
2022-01-14
Recruiting
Blueprint Medicines Corporation
Phase 2/3
534
Stockholm, Uppsala
2021-11-30
Active, closed
Janssen Research & Development, LLC
Phase 3
776
Gothenburg, Linköping, Lund, Umeå, Uppsala
2021-11-17
Active, closed
Janssen Research & Development, LLC
Phase 3
587
Falun, Gothenburg, Helsingborg, Luleå, Lund, Umeå, Uppsala
2021-10-14
Active, closed
StUdy oN Burst Fractures (SunBurst)
NCT05003180Thoracolumbar Burst Fracture
Uppsala University
Not applicable
202
Gothenburg, Linköping, Malmö, Stockholm, Umeå, Uppsala, Halmstad, Jönköping
2021-09-01
Active, closed
Janssen Research & Development, LLC
Phase 4
411
Solna, Uppsala
2021-08-30
Active, closed
Hoffmann-La Roche
Phase 3
4,170
Jönköping, Stockholm, Sundsvall, Uppsala, Västerås
2021-08-27
Active, closed
Janssen Pharmaceutica N.V., Belgium
Observational
1,314
Gothenburg, Malmö, Örebro, Stockholm, Uppsala
2021-08-25
Recruiting
Merck Sharp & Dohme LLC
Phase 2
355
Lund, Stockholm, Uppsala, Gothenburg
2021-08-12
Recruiting
Biomarkers of Brain Injury in Children With Brain Tumors
NCT07381959Brain Tumor, Childhood Cancer, Childhood Brain Tumor
Uppsala University
Observational
560
Uppsala
2021-08-01
Active, closed
Britannia Pharmaceuticals Ltd.
Observational
312
Gothenburg, Lund, Uppsala
2021-07-06
Active, closed
AstraZeneca
Phase 3
506
Gothenburg, Lund, Uppsala
2021-06-22
Recruiting
Functional Outcome After ORIF or Arthroplasty for Femoral Neck Fracture
NCT06152198Hip Fractures, Femoral Neck Fractures, Undisplaced Fracture, Treatment Complication
Uppsala University
Not applicable
340
Uppsala
2021-06-20
Recruiting
Evaluation of Primary Care Behavioral Health (PCBH) With the Addition of Self-help CBT - A Randomized Multicenter Trial
NCT04900064Panic Disorder, Social Anxiety Disorder, Depression, Hypochondriasis
Linnaeus University
Not applicable
1,242
Varberg, Malmö, Stockholm, Uppsala
2021-06-14
Recruiting
Betalactam Pharmacokinetics in Endocarditis Patients
NCT04647331Infective Endocarditis
Uppsala University
Observational
150
Gothenburg, Lund, Stockholm, Uppsala
2021-06-01
Recruiting
Efficacy of Hyperthermic Intraperitoneal Chemotherapy
NCT04861558Colorectal Cancer, Peritoneal Metastases
Drugs5Fluorouracil·Irinotecan·Oxaliplatin
Uppsala University
Phase 3
213
Gothenburg, Malmö, Stockholm, Uppsala
2021-05-01
Active, closed
AstraZeneca
Phase 3
1,157
Gothenburg, Örebro, Stockholm, Uppsala, Vaxjo
2021-04-26
Recruiting
Alexander Valdman
Not applicable
254
Stockholm, Gävle, Gothenburg, Linköping, Lund, Sundsvall, Umeå, Uppsala
2021-04-20
Active, closed
Incyte Corporation
Phase 3
654
Solna, Uddevalla, Uppsala
2021-04-15
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,688
Jönköping, Stockholm, Uppsala, Umeå, Gothenburg
2021-04-14
Recruiting
Umeå University
Not applicable
100
Gothenburg, Lund, Umeå, Uppsala
2021-04-07
Active, closed
Treatment of Olecranon Fractures in the Elderly
NCT04670900Olecranon Fracture
Oslo University Hospital
Not applicable
76
Uppsala
2021-03-22
Active, closed
Artificial Intelligence Supporting CAncer Patients Across Europe - the ASCAPE Project
NCT04879563Breast Cancer, Prostate Cancer, Quality of Life, Survivorship
Region Örebro County
Phase 2
500
Örebro, Uppsala
2021-02-01
Active, closed
Merck Sharp & Dohme LLC
Phase 3
990
Solna, Uppsala, Linköping
2021-01-10
Active, closed
Pfizer
Phase 3
841
Solna, Uppsala, Umeå, Gothenburg, Stockholm
2020-12-21
Active, closed
GlaxoSmithKline
Phase 2/3
758
Gävle, Stockholm, Uppsala
2020-12-08
Recruiting
Karolinska University Hospital
Phase 3
1,020
Linköping, Lund, Örebro, Stockholm, Umeå, Uppsala
2020-11-27
Active, closed
AbbVie
Phase 1
21
Uppsala, Örebro
2020-11-11
Recruiting
Meril Life Sciences Pvt. Ltd.
Not applicable
988
Gothenburg, Uppsala
2020-11-04
Active, closed
Genmab
Phase 1/2
543
Borås, Gothenburg, Lund, Solna, Uppsala
2020-11-03
Active, closed
Bayer
Phase 3
774
Stockholm, Uppsala, Umeå, Gothenburg
2020-10-20
Active, closed
Annika Bergquist
Phase 3
571
Malmö, Umeå, Gothenburg, Karlstad, Lidköping, Örebro, Stockholm, Uppsala
2020-10-01
Recruiting
Evaluation of a Renin Inhibitor, Aliskiren, Compared to Enalapril, in C3 Glomerulopathy
NCT04183101C3 Glomerulopathy, Membranoproliferative Glomerulonephritis, Complement Abnormality, Dense Deposit Disease
DrugEnalapril
Region Skane
Phase 2
30
Gothenburg, Lund, Stockholm, Uppsala
2020-10-01
Active, closed
Hoffmann-La Roche
Phase 3
190
Uppsala
2020-09-30
Recruiting
University of Birmingham
Phase 1/2
1,672
Uppsala
2020-09-17
Active, closed
AstraZeneca
Phase 3
866
Gothenburg, Örebro, Stockholm, Uppsala, Vaxjo
2020-07-24
Recruiting
Mats Heyman
Phase 3
6,430
Gothenburg, Linköping, Lund, Örebro, Stockholm, Umeå, Uppsala
2020-07-13
Active, closed
Supramarginal Resection in Glioblastoma
NCT04243005Glioblastoma
St. Olavs Hospital
Not applicable
90
Gothenburg, Stockholm, Umeå, Uppsala
2020-07-01
Active, closed
Janssen Research & Development, LLC
Phase 3
419
Lund, Stockholm, Uppsala
2020-06-12
Recruiting
Delayed Sentinel Lymph Node Biopsy in Ductal Cancer in Situ
NCT04722692DCIS, Breast Cancer, Breast Neoplasms, Sentinel Lymph Node
Uppsala University
Phase 3
500
Falun, Vaxjo, Lund, Västerås, Gothenburg, Uppsala, Linköping
2020-03-01
Active, closed
Delayed SLND for Patients With Breast Cancer Undergoing Primary Systemic Treatment
NCT05985551Breast Cancer, Chemotherapy Effect, Sentinel Lymph Node
Uppsala University
Observational
114
Uppsala
2020-01-01
Active, closed
The Netherlands Cancer Institute
Phase 3
538
Uppsala
2020-01-01
Recruiting
Oncologic, Cosmetic and Patient Reported Outcomes in Value-Based Breast Surgery (OnCoPRO Value)
NCT06401304Breast Cancer, Breast Carcinoma in Situ, Breast Cancer Invasive, Breast Asymmetry
Uppsala University
Observational
1,200
Uppsala
2020-01-01
Active, closed
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
777
Lund, Stockholm, Uppsala
2019-12-20
Recruiting
High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)
NCT04221035High-Risk Neuroblastoma, Patient With Insufficient Response Chemoimmunotherapy
DrugsDinutuximab beta·Vindesine·Cyclophosphamid·Thiotepa
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3
800
Gothenburg, Linköping, Lund, Stockholm, Umeå, Uppsala
2019-11-05
Active, closed
Orbital Fractures Registry
NCT03887988Orbital Fractures, Blow Out Fracture of Orbit
AO Innovation Translation Center
Observational
300
Uppsala
2019-11-01
Recruiting
Alloplastic Total Temporomandibular Joint (TMJ) Replacement Registry
NCT03991728Temporomandibular Joint Disorders
AO Innovation Translation Center
Observational
200
Falun, Lund, Stockholm, Uppsala
2019-10-15
Recruiting
Associazione Italiana Ematologia Oncologia Pediatrica
Phase 2
89
Uppsala
2019-10-09
Active, closed
Janssen Research & Development, LLC
Phase 2/3
1,064
Stockholm, Uppsala
2019-09-26
Recruiting
Uppsala University
Not applicable
1,440
Uppsala, Alingsås, Borås, Falun, Gävle, Gothenburg, Jönköping, Kalmar
2019-09-16
Recruiting
Combining Active and Passive DNA Hypomethylation
NCT03999723Myelodysplastic Syndromes, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia
Kirsten Grønbæk
Phase 2
196
Gothenburg, Lund, Stockholm, Uppsala
2019-09-11
Recruiting
Uppsala University Hospital
Not applicable
75
Gothenburg, Lund, Örebro, Solna, Umeå, Uppsala
2019-09-01
Recruiting
Mats Heyman
Observational
500
Gothenburg, Linköping, Lund, Örebro, Stockholm, Umeå, Uppsala
2019-08-29
Recruiting
University Hospital Muenster
Phase 3
683
Gothenburg, Linköping, Lund, Stockholm, Umeå, Uppsala
2019-08-23
Recruiting
Karolinska Institutet
Not applicable
20,000
Luleå, Lund, Gothenburg, Jönköping, Stockholm, Uppsala
2019-08-19
Active, closed
Merck Sharp & Dohme LLC
Phase 3
595
Jönköping, Stockholm, Uppsala, Umeå, Gothenburg
2019-07-24
Active, closed
Tesaro, Inc.
Phase 3
785
Linköping, Lund, Stockholm, Uppsala
2019-07-18
Recruiting
Population Health Research Institute
Phase 4
2,270
Danderyd, Uppsala
2019-06-14
Recruiting
Uppsala University
Observational
300
Uppsala
2019-05-15
Active, closed
Blueprint Medicines Corporation
Phase 2
251
Stockholm, Uppsala
2019-04-16
Active, closed
Eisai Inc.
Phase 3
1,906
Gothenburg, Malmö, Stockholm, Uppsala
2019-03-27
Active, closed
AbbVie
Phase 3
964
Malmö, Falun, Solna, Uppsala, Västerås, Örebro
2019-03-25
Active, closed
AbbVie
Phase 3
444
Solna, Uppsala, Västerås, Örebro
2019-03-07
Active, closed
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
968
Lund, Stockholm, Uppsala
2019-03-01
Active, closed
Acerta Pharma BV
Phase 3
984
Gothenburg, Örebro, Uppsala
2019-02-25
Active, closed
Human Milk Fortification in Extremely Preterm Infants
NCT03797157Necrotizing Enterocolitis, Sepsis, Mortality
Thomas Abrahamsson, MD, PhD
Phase 2/3
229
Gothenburg, Linköping, Stockholm, Umeå, Uppsala
2019-02-01
Active, closed
Janssen Research & Development, LLC
Phase 3
765
Stockholm, Uppsala
2019-01-25
By invitation
Long-Term Opioid Therapy in Chronic Non-Cancer Pain: Risks and Benefits
NCT06063902Chronic Non-Cancer Pain, Opioid Use Disorder
Uppsala University
Observational
1,000
Uppsala
2019-01-14
Recruiting
Multisite Inventory of Neonatal-Perinatal Interventions (MINI) Minimum Dataset
NCT05685745Infant, Extremely Premature, Obstetric Labor, Premature, Premature Birth, Intensive Care, Neonatal
The University of Texas Health Science Center, Houston
Observational
5,000
Uppsala
2019-01-01
Active, closed
Uppsala University
Not applicable
3,933
Uppsala
2018-10-25
Recruiting
Partial Breast Versus no Irradiation for Women With Early Breast Cancer
NCT03646955Local Neoplasm Recurrence, Distantly Metastatic Malignant Neoplasm, Death, Fibrosis Breast
Danish Breast Cancer Cooperative Group
Not applicable
926
Gothenburg, Lund, Uppsala
2018-09-05
Recruiting
Merck Sharp & Dohme LLC
Phase 3
3,500
Stockholm, Uppsala, Umeå, Gothenburg
2018-08-21
Recruiting
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
NCT03583710ENSAT Stage I Adrenal Cortex Carcinoma, ENSAT Stage II Adrenal Cortex Carcinoma, ENSAT Stage III Adrenal Cortex Carcinoma
DrugsMitotane·Cis-platinum·CDDP·Platinol-AQ
M.D. Anderson Cancer Center
Phase 3
240
Gothenburg, Lund, Stockholm, Uppsala
2018-08-20
Recruiting
The Swedish Essential Tremor (SWEET) Trial
NCT03832712Essential Tremor
Karolinska Institutet
Not applicable
100
Gothenburg, Linköping, Lund, Stockholm, Umeå, Uppsala
2018-06-30
Active, closed
Vastra Gotaland Region
Phase 4
2,201
Gothenburg, Karlskrona, Linköping, Lund, Örebro, Stockholm, Umeå, Uppsala
2018-06-29
Active, closed
First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma
NCT03625037DLBCL, High-grade B-cell Lymphoma (HGBCL), Primary Mediastinal Large B-cell Lymphoma (PMBCL), FL
DrugEpcoritamab
Genmab
Phase 1/2
666
Lund, Stockholm, Uppsala
2018-06-26
By invitation
Helsinki University Central Hospital
Observational
200
Lund, Stockholm, Sundsvall, Uppsala
2018-06-01
Recruiting
BioInvent International AB
Phase 1/2
140
Uppsala, Lund
2018-05-16
Active, closed
Bristol-Myers Squibb
Phase 2/3
714
Gothenburg, Lund, Solna, Uppsala
2018-04-11
Active, closed
Haukeland University Hospital
Phase 3
100
Gothenburg, Uppsala
2018-03-21
Recruiting
Jeanette Lundin
Phase 1/2
50
Falun, Gävle, Lund, Gothenburg, Örebro, Stockholm, Umeå, Uppsala
2018-02-23
Recruiting
Inflammatory Mediators of Acute Kidney Injury in Intensive Care
NCT03720860Sepsis, Surgery, Acute Kidney Injury
Uppsala University
Observational
100
Uppsala
2018-01-01
Active, closed
BeiGene
Phase 3
590
Borås, Gothenburg, Lund, Örebro, Stockholm, Uppsala
2017-10-31
Active, closed
Uppsala University
Not applicable
30
Uppsala
2017-09-01
Active, closed
University Hospital Muenster
Phase 3
650
Gothenburg, Linköping, Lund, Stockholm, Umeå, Uppsala
2017-08-03
Active, closed
Lateral Episiotomy or Not in Vacuum Assisted Delivery in Non-parous Women
NCT02643108Pelvic Floor Disorders, Fecal Incontinence, Dystocia, Fetal Hypoxia
Karolinska Institutet
Not applicable
717
Falun, Gothenburg, Helsingborg, Stockholm, Umeå, Uppsala, Vaxjo
2017-06-30
Active, closed
Karolinska Institutet
Not applicable
750
Gothenburg, Lund, Örebro, Stockholm, Uppsala
2017-05-03
Recruiting
Karolinska Institutet
Not applicable
30
Uppsala
2017-02-02
Active, closed
AbbVie
Phase 3
443
Uppsala, Uddevalla, Lund, Stockholm
2017-02-02
Active, closed
BROnchoalveolar Investigations of Never-smokers With Chronic Obstruction From the Swedish CardioPulmonary bioImage Study
NCT03049202Chronic Obstructive Pulmonary Disease, Emphysema, Chronic Bronchitis, Airway Obstruction
Karolinska Institutet
Observational
1,000
Stockholm, Gothenburg, Linköping, Lund, Umeå, Uppsala
2017-02-01
Active, closed
Uppsala University
Not applicable
2,008
Gothenburg, Linköping, Luleå, Örebro, Sundsvall, Umeå, Uppsala, Vaxjo
2016-10-03
Active, closed
Oslo University Hospital
Phase 2/3
140
Gothenburg, Huddinge, Linköping, Lund, Umeå, Uppsala
2016-09
Active, closed
Tesaro, Inc.
Phase 3
733
Stockholm, Uppsala
2016-07-11
Active, closed
Vastra Gotaland Region
Not applicable
74
Gothenburg, Linköping, Lund, Örebro, Stockholm, Umeå, Uppsala
2016-06
Active, closed
Uppsala University
Phase 1/2
35
Uppsala
2016-03
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 3
1,052
Gothenburg, Malmö, Örebro, Stockholm, Umeå, Uppsala, Vaxjo
2015-11-27
Active, closed
AstraZeneca
Phase 3
953
Eskilstuna, Linköping, Stockholm, Uppsala
2015-11-03
Active, closed
Nutrition and Inflammation in Patients With Head and Neck Cancer
NCT03343236Head and Neck Neoplasms, Radiotherapy Side Effect, Inflammation, Metabolism
Uppsala University
Observational
522
Uppsala
2015-11-01
Recruiting
Proton Radiotherapy for Primary Central Nervous System Tumours in Adults
NCT02797366Central Nervous System Tumour, Arteriovenous Malformation
Uppsala University
Phase 2
500
Gothenburg, Linköping, Örebro, Stockholm, Umeå, Uppsala
2015-08
Active, closed
Alliance Foundation Trials, LLC.
Phase 3
5,796
Gävle, Gothenburg, Örebro, Stockholm, Uppsala
2015-08
Active, closed
Medtronic
Observational
3,100
Uppsala
2015-07
Recruiting
Uppsala-Dalarna Dementia and Gait Project
NCT05893524Dementia, Dementia, Mixed, Dementia Senile, Dementia of Alzheimer Type
Dalarna University
Observational
550
Falun, Uppsala
2015-04-09
Active, closed
Exelixis
Phase 4
247
Lund, Uppsala
2015-02-25
Active, closed
Pfizer
Phase 3
1,068
Gothenburg, Malmö, Örebro, Stockholm, Umeå, Uppsala
2014-12-17
Active, closed
Neoadjuvant Response-guided Treatment of HER2 Positive Breast Cancer
NCT02568839Early-Stage Breast Carcinoma, HER-2 Positive Breast Cancer
DrugsTrastuzumab emtansine·Pertuzumab·Trastuzumab·Docetaxel
Thomas Hatschek
Phase 2/3
202
Örebro, Gothenburg, Lund, Stockholm, Sundsvall, Umeå, Uppsala
2014-11
Recruiting
Cerebellar Mutism Syndrome Study
NCT02300766Infratentorial Neoplasms, Mutism
Copenhagen University Hospital, Rigshospitalet
Observational
2,000
Gothenburg, Linköping, Skåne, Stockholm, Umeå, Uppsala
2014-10
Recruiting
Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors
NCT01356290Medulloblastoma Recurrent, Ependymoma Recurrent, ATRT Recurrent, Rare CNS Tumor Recurrent
DrugsThalidomide·Celecoxib·Temozolomide·Cytarabine
Medical University of Vienna
Phase 2
232
Gothenburg, Linköping, Lund, Stockholm, Umeå, Uppsala
2014-04
Active, closed
Uppsala University Hospital
Phase 1/2
4
Uppsala
2014-02
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 3
1,207
Gothenburg, Örebro, Stockholm, Umeå, Uppsala
2013-10-14
Active, closed
AstraZeneca
Phase 3
510
Linköping, Örebro, Uppsala
2013-09-25
Recruiting
Javier P. Gisbert
Observational
10,000
Uppsala
2013-06
Recruiting
St. Anna Kinderkrebsforschung
Phase 2/3
1,800
Gothenburg, Lund, Stockholm, Uppsala
2013-04
Active, closed
The SCAPIS-Snus Study
NCT07573319Nicotine, Mental Health, Cardiovascular (CV) Risk, Metabolic Abnormalities
Karolinska Institutet
Observational
30,154
Gothenburg, Lund, Stockholm, Umeå, Uppsala
2013-01-01
By invitation
Texas Scottish Rite Hospital for Children
Observational
1,500
Uppsala
2012-08
Active, closed
Eli Lilly and Company
Phase 2
110
Stockholm, Uddevalla, Uppsala
2012-05-22
Recruiting
Medtronic
Observational
20,000
Gothenburg, Lund, Skövde, Uppsala
1983-01
Rows per page Showing 1–368 of 368
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Swedish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 November 2026. https://priyalifescience.com/clinical-trials-sweden/city/uppsala

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Sweden and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,214 studies in total at the last sync on 12 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 368 of those studies with a site in Uppsala.

How many clinical trials are recruiting in Uppsala?

214 of the 368 studies on this page are recruiting new participants as of the 12 Nov 2026, 03:17 UTC sync. A further 24 have not yet opened recruitment, 124 are active but closed to new participants, and 6 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Uppsala), 368 studies
PhaseStudiesRecruitingShare
Phase 31346636.4%
Not applicable876123.6%
Observational724419.6%
Phase 230198.2%
Phase 1/21363.5%
Phase 2/31363.5%
Phase 41052.7%
Phase 1862.2%
Early Phase 1110.3%

Most active sponsors

Lead sponsors with the most studies (Uppsala)
Lead sponsorStudiesRecruiting
Uppsala University7048
AstraZeneca2511
Karolinska Institutet1912
Merck Sharp & Dohme LLC189
Uppsala University Hospital1711
Janssen Research & Development, LLC156
Boehringer Ingelheim84
GlaxoSmithKline87
Bristol-Myers Squibb75
Vastra Gotaland Region74
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.